Journal Articles
Prescribed safer opioid supply: A scoping review of the evidence
This study examined outcomes experienced by clients participating in formal safer opioid supply programs, as well as the perceptions of both clients and providers involved in these programs.
February 8, 2024
This study investigated the duration of naltrexone use among individuals in Ontario who initiated therapy for alcohol use disorder, and if the healthcare setting where naltrexone was prescribed had an impact on the time to therapy discontinuation.
January 31, 2024
This study examined the impact of the COVID-19 pandemic on prescription stimulant use among individuals aged 0 to 24 in Ontario, Canada.
January 5, 2024
This study examined treatment duration among people initiating methadone or buprenorphine/naloxone in Ontario, Canada, and whether retention varies according to age, sex, and urban/rural residence.
January 4, 2024
Public Reports and Tools
This joint report by the ODPRN and Public Health Ontario describes prior prescribing patterns, previous substance use diagnoses, non-fatal substance-related toxicities and access to treatment(s) prior to accidental substance-related toxicity deaths involving opioids, benzodiazepines, stimulants and/or alcohol in Ontario between January 2018 and June 2022.
March 5, 2024
Journey with Depression: Town Hall on Experiences Accessing Treatment and Services for Depression
The objective of this Town Hall and of this document is to identify patient-oriented research needs and gaps or opportunities for improvement in the healthcare system that can be used by researchers, clinicians and policymakers to improve access to treatment and services for depression.
January 11, 2024
This report builds on the results reported in the initial 2021 report and examines the trends and patterns in opioid prescribing, access to treatment, and opioid-related toxicity among First Nations in Ontario up to the end of 2021.
November 24, 2023
This report describes trends and circumstances surrounding fatal substance-related toxicities broadly in Ontario, combining data on deaths due to alcohol, stimulants, benzodiazepines, and opioids.
September 14, 2023